Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2Phase 4 1Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Breast Neoplasms 3Neoplasms 2NSCLC 2Lymphoma, Non-Hodgkin 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Solid Tumor Regardless of Localization and Stage 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Lymphoma, Extranodal NK-T-Cell 1Localized Advanced Rectal Adenocarcinoma 1Liver Neoplasms 1HER-2 Negative Breast Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Acute Kidney Injury 1

Interventions

Dexamethasone 11Lenalidomide 10Bortezomib 9Zoledronic Acid 8ixazomib 4daratumumab 4Melphalan 4tocilizumab 3Thalidomide 3Cyclophosphamide 3pomalidomide 2carfilzomib 2Prednisone 2Kyphoplasty 2Filgrastim 2Doxorubicin 2Calcium Dobesilate 2zanubrutinib 1talquetamab 1pegylated granulocyte colony-stimulating factor 1montelukast 1isatuximab 1ibrutinib 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1apixaban 1Vaccination 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Multiple Myeloma × Drug Therapy × Clear all
NCT05429515 2022-06-23

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Peking Union Medical College Hospital

Phase 4 Not yet recruiting
50 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡